Humanin vs Taurine
A side-by-side research comparison of Humanin and Taurine across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Humanin | Taurine |
|---|---|---|
| Full name | Humanin (HN) Mitochondrial-Derived Peptide | Taurine (2-Aminoethanesulfonic Acid) |
| Category | Anti-Aging | Anti-Aging |
| Status | Research compound | OTC supplement |
| Mechanism | Binds IGFBP-3, BAX, and trimeric receptor (CNTFR/WSX-1/gp130) to activate STAT3. Inhibits mitochondrial apoptosis and provides neuroprotection. | Acts as a cytoprotective osmolyte and antioxidant, stabilizes mitochondrial function, modulates calcium signaling and GABA-A/glycine receptors, reduces inflammation, and supports bile acid conjugation. Taurine deficiency accelerates cellular senescence markers. |
| Molecular weight | 2,687 Da | 125.15 Da |
| Half-life | 4-6 hours | ~1 hour (plasma) |
| Bioavailability | Moderate (SubQ) | ~90-100% oral |
| Typical dose | 1-5 mg | 1-6 g per day |
| Frequency | 3-5x per week | 1-3x daily |
| Route | Subcutaneous | Oral (powder or capsule) |
Humanin reported benefits
- Neuroprotection against amyloid-beta
- Anti-apoptotic
- Improved insulin sensitivity
- Cardioprotection
- Cellular stress resistance
Taurine reported benefits
- Supports mitochondrial function
- Cardiovascular and blood pressure support
- Exercise endurance
- Antioxidant and anti-inflammatory
- Longevity/healthspan signal
- Calming/GABAergic effects
Related comparisons
Research and educational reference only. Not medical advice.